272 related articles for article (PubMed ID: 28321282)
21. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.
Birungi J; Cui Z; Okoboi S; Kapaata A; Munderi P; Mukajjanga C; Nanfuka M; Nyonyintono MS; Kim J; Zhu J; Kaleebu P; Moore DM
HIV Med; 2020 Jan; 21(1):21-29. PubMed ID: 31432614
[TBL] [Abstract][Full Text] [Related]
22. Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.
Todd S; Rafferty P; Walker E; Hunter M; Dinsmore WW; Donnelly CM; McCarty EJ; Quah SP; Emerson CR
Int J STD AIDS; 2017 Oct; 28(11):1074-1081. PubMed ID: 28118801
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of genital infections in medical inpatients in Blantyre, Malawi.
Maher D; Hoffman I
J Infect; 1995 Jul; 31(1):77-8. PubMed ID: 8522842
[TBL] [Abstract][Full Text] [Related]
24. Point-of-Care Viral Load Testing to Manage HIV Viremia During the Rollout of Dolutegravir-Based ART in South Africa: A Randomized Feasibility Study (POwER).
Dorward J; Sookrajh Y; Lessells R; Bulo E; Naidoo J; Naidoo K; Bodley N; Khanyile M; Van Vuuren CJ; Moodley P; Samsunder N; Lewis L; Drain PK; Hayward G; Butler CC; Garrett N
J Acquir Immune Defic Syndr; 2023 Aug; 93(5):403-412. PubMed ID: 37120720
[TBL] [Abstract][Full Text] [Related]
25. Timeliness of Point-of-Care Viral Load Results Improves Human Immunodeficiency Virus Monitoring in Nigeria.
Chaplin B; Agbaji O; Reyes Nieva H; Olatunde B; Chang C; Mitruka K; Sule H; Dajel T; Zee A; Ahmed ML; Ahmed I; Okonkwo P; Rawizza H; Kanki P
Clin Infect Dis; 2023 Feb; 76(3):e671-e680. PubMed ID: 35872644
[TBL] [Abstract][Full Text] [Related]
26. Expanded access to viral load testing and use of second line regimens in Haiti: time trends from 2010-2017.
Wang Y; Barnhart S; Francois K; Robin E; Kalou M; Perrin G; Hall L; Koama JB; Marinho E; Balan JG; Honoré JG; Puttkammer N
BMC Infect Dis; 2020 Apr; 20(1):283. PubMed ID: 32299389
[TBL] [Abstract][Full Text] [Related]
27. When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a
Labhardt ND; Ringera I; Lejone TI; Cheleboi M; Wagner S; Muhairwe J; Klimkait T
J Int AIDS Soc; 2017 Jul; 20(1):21803. PubMed ID: 28777506
[TBL] [Abstract][Full Text] [Related]
28. Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort.
Hawkins C; Hertzmark E; Spiegelman D; Muya A; Ulenga N; Kim S; Khudyakov P; Christian B; Sando D; Aris E; Fawzi W
J Antimicrob Chemother; 2017 Jul; 72(7):2060-2068. PubMed ID: 28387836
[TBL] [Abstract][Full Text] [Related]
29. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?
Saunders P; Goodman AL; Smith CJ; Marshall N; O'Connor JL; Lampe FC; Johnson MA
HIV Med; 2016 Jan; 17(1):18-27. PubMed ID: 26140659
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China.
Wang J; Wang Z; Liu J; Yue Y; Yang S; Huang H; He C; Liao L; Xing H; Ruan Y; Shao Y
Sci Rep; 2015 Oct; 5():14823. PubMed ID: 26445885
[TBL] [Abstract][Full Text] [Related]
31. Routine versus Targeted Viral Load Strategy among Patients Starting Antiretroviral in Hanoi, Vietnam.
Pollack TM; Duong HT; Pham TT; Nguyen TD; Libman H; Ngo L; McMahon JH; Elliott JH; Do CD; Colby DJ
J Int AIDS Soc; 2019 Mar; 22(3):e25258. PubMed ID: 30897303
[TBL] [Abstract][Full Text] [Related]
32. Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: An insight into the clinic-laboratory interface.
Awungafac G; Amin ET; Fualefac A; Takah NF; Agyingi LA; Nwobegahay J; Ondoa P; Njukeng PA
PLoS One; 2018; 13(6):e0198686. PubMed ID: 29889862
[TBL] [Abstract][Full Text] [Related]
33. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland.
Etoori D; Ciglenecki I; Ndlangamandla M; Edwards CG; Jobanputra K; Pasipamire M; Maphalala G; Yang C; Zabsonre I; Kabore SM; Goiri J; Teck R; Kerschberger B
J Int AIDS Soc; 2018 Oct; 21(10):e25194. PubMed ID: 30350392
[TBL] [Abstract][Full Text] [Related]
34. Validation of the Viral Load Testing Criteria - an algorithm for targeted viral load testing in HIV-positive adults receiving antiretroviral therapy.
Thorman J; Björkman P; Tesfaye F; Jeylan A; Balcha TT; Reepalu A
Trop Med Int Health; 2019 Mar; 24(3):356-362. PubMed ID: 30624826
[TBL] [Abstract][Full Text] [Related]
35. Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.
Khan S; Das M; Andries A; Deshpande A; Mansoor H; Saranchuk P; Isaakidis P
Glob Health Action; 2014; 7():24861. PubMed ID: 25084835
[TBL] [Abstract][Full Text] [Related]
36. Natural polymorphisms in HIV-1 protease: impact on effectiveness of a first-line lopinavir-containing antiretroviral therapy regimen.
Champenois K; Deuffic-Burban S; Cotte L; André P; Choisy P; Ajana F; Bocket L; Yazdanpanah Y
J Med Virol; 2008 Nov; 80(11):1871-9. PubMed ID: 18814256
[TBL] [Abstract][Full Text] [Related]
37. Impact of point-of-care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas).
Patel RC; Oyaro P; Thomas KK; Basha GW; Wagude J; Mukui I; Brown E; Hassan SA; Kinywa E; Oluoch F; Odhiambo F; Oyaro B; Kingwara L; Karauki E; Yongo N; Otieno L; John-Stewart GC; Abuogi LL
J Int AIDS Soc; 2023 Nov; 26(11):e26182. PubMed ID: 37938856
[TBL] [Abstract][Full Text] [Related]
38. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study.
Nsanzimana S; Semakula M; Ndahindwa V; Remera E; Sebuhoro D; Uwizihiwe JP; Ford N; Tanner M; Kanters S; Mills EJ; Bucher HC
BMC Infect Dis; 2019 Apr; 19(1):312. PubMed ID: 30953449
[TBL] [Abstract][Full Text] [Related]
39. Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: FREE randomized trial interim results.
Sprenger HG; Langebeek N; Mulder PG; Ten Napel CH; Vriesendorp R; Hoepelman AI; Legrand JC; Koopmans PP; Van Kasteren ME; Bravenboer B; Ten Kate RW; Groeneveld PH; van der Werf TS; Gisolf EH; Richter C
AIDS Patient Care STDS; 2010 Jun; 24(6):361-6. PubMed ID: 20515418
[TBL] [Abstract][Full Text] [Related]
40. Outcome of patients on second line antiretroviral therapy under programmatic condition in India.
Chakravarty J; Sundar S; Chourasia A; Singh PN; Kurle S; Tripathy SP; Chaturbhuj DN; Rai M; Agarwal AK; Mishra RN; Paranjape RS
BMC Infect Dis; 2015 Nov; 15():517. PubMed ID: 26572102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
